Health Canada approves Pfizer's gene therapy for treatment of hemophilia
CBC
Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision.
The approval was based on late-stage trials that showed a single dose of the therapy, to be sold under the brand name Beqvez, was superior to the current standard of care which involves replacing a blood-clotting protein called factor IX, according to the company's release.
The therapy is for patients over 18 living with moderately severe to severe hemophilia B.
The U.S. Food and Drug Administration (FDA) had in November 2022 approved pharmaceutical company CSL's product Hemgenix, making it the first one-time gene therapy for hemophilia B.
CSL had acquired exclusive global rights to Hemgenix from gene therapy maker uniQure NV in 2021.
Pfizer is also seeking U.S. approval for its experimental antibody, marstacimab, to treat hemophilia A and B.
Beqvez is listed as an approved product on Health Canada's online database. CBC News reached out to Health Canada for comment on Pfizer's announcement.
Hemophilia is a hereditary condition in which blood does not clot normally, according to the Canadian Hemophilia Society. Patients who have the condition bleed spontaneously, excessively or for a longer time than is typical.
Hemophilia B is found in 1 in 40,000 people and represents about 15 per cent of patients with hemophilia, according to the FDA.
The U.S. health regulator is expected to give its decision on Pfizer's therapy in the second quarter of 2024.
A First Nations family recently appeared on a popular U.S. daytime talk show to showcase their own styles of powwow dance.
People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral self-test.
Indiana University in Bloomington, Ind., is working with Nakota communities to return valuable cultural archives of recordings of their elders.
Children face five major risk factors early in life that can set them up to develop food allergies, says a Canadian-led team of researchers who sifted through studies on 2.8 million participants in 40 countries, one of the largest reviews of its kind.
Deep within a dark growing chamber in the bowels of a research lab at Acadia University, a lumpy white substance blooms up from an industrial tray.
Most of the world doesn’t require a prescription for birth control. Why do Canadians still need one?
Leah Morris has been on birth control since she was a teenager. She remembers that first appointment being deceptively simple.
Nearly $300M in federal contracts went to companies later removed from Indigenous Business Directory
Over $285 million in federal government contracts for Indigenous businesses were awarded over a five-year period to companies that have since been removed from its Indigenous Business Directory, according to a response to a written question in the House of Commons.
The Artemis II mission, which was initially supposed to launch on Feb. 8, has now been delayed by at least a month after NASA found a hydrogen leak while fuelling the tank.
Facing the reality that a majority of Canadian students are using generative AI for schoolwork, more educators are bringing artificial intelligence into their university classrooms, setting clear rules and encouraging students to use it responsibly — and with a critical eye.
Five more First Nations have joined a court challenge against new federal and provincial laws aimed at fast-tracking development, saying they threaten Indigenous rights.
Scientists who monitor Canada’s environmental health and protect Canadians from extreme weather events and industrial disasters could soon find themselves on the federal government’s chopping block.
The federal government is reviving proposed legislation that would allow digital health information to be shared safely across electronic systems, giving both patients and providers access to more comprehensive medical records.
Some First Nations in Saskatchewan will hold information sessions about making claims under the Federal Indian Hospitals Settlement. One lawyer from Keeseekoose First Nation says having to revisit the experience can be difficult and she wants to help.